Ryan Specialty Holdings, Inc. (NYSE:RYAN) Director Nicholas Dominic Cortezi Sells 35,000 Shares

Ryan Specialty Holdings, Inc. (NYSE:RYANGet Free Report) Director Nicholas Dominic Cortezi sold 35,000 shares of the stock in a transaction on Friday, January 17th. The shares were sold at an average price of $67.15, for a total transaction of $2,350,250.00. Following the transaction, the director now directly owns 25,809 shares in the company, valued at approximately $1,733,074.35. This represents a 57.56 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Nicholas Dominic Cortezi also recently made the following trade(s):

  • On Tuesday, January 21st, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $66.35, for a total transaction of $2,322,250.00.
  • On Wednesday, January 15th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $65.99, for a total value of $2,309,650.00.
  • On Monday, January 13th, Nicholas Dominic Cortezi sold 29,466 shares of Ryan Specialty stock. The shares were sold at an average price of $65.06, for a total value of $1,917,057.96.
  • On Friday, December 20th, Nicholas Dominic Cortezi sold 91 shares of Ryan Specialty stock. The shares were sold at an average price of $65.00, for a total value of $5,915.00.
  • On Wednesday, December 18th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $65.17, for a total transaction of $2,280,950.00.
  • On Monday, December 16th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $66.71, for a total transaction of $2,334,850.00.
  • On Friday, December 13th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $67.39, for a total transaction of $2,358,650.00.

Ryan Specialty Stock Up 0.2 %

RYAN traded up $0.13 during midday trading on Tuesday, reaching $66.73. The company’s stock had a trading volume of 768,093 shares, compared to its average volume of 1,051,816. Ryan Specialty Holdings, Inc. has a 1 year low of $42.21 and a 1 year high of $75.97. The stock’s 50-day moving average is $67.84 and its 200-day moving average is $66.06. The firm has a market capitalization of $17.47 billion, a price-to-earnings ratio of 86.66, a PEG ratio of 1.19 and a beta of 0.72. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40.

Ryan Specialty (NYSE:RYANGet Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, hitting the consensus estimate of $0.41. The company had revenue of $604.69 million for the quarter, compared to the consensus estimate of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The firm’s quarterly revenue was up 20.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.32 EPS. As a group, research analysts expect that Ryan Specialty Holdings, Inc. will post 1.82 EPS for the current year.

Ryan Specialty Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th were given a $0.11 dividend. This represents a $0.44 annualized dividend and a dividend yield of 0.66%. The ex-dividend date of this dividend was Tuesday, November 12th. Ryan Specialty’s dividend payout ratio is presently 57.14%.

Hedge Funds Weigh In On Ryan Specialty

A number of hedge funds have recently bought and sold shares of RYAN. Xponance Inc. raised its holdings in Ryan Specialty by 67.2% in the second quarter. Xponance Inc. now owns 20,686 shares of the company’s stock worth $1,198,000 after buying an additional 8,312 shares during the last quarter. Jennison Associates LLC increased its position in shares of Ryan Specialty by 60.2% during the third quarter. Jennison Associates LLC now owns 1,025,063 shares of the company’s stock valued at $68,054,000 after acquiring an additional 385,366 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in Ryan Specialty by 107.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company’s stock worth $30,504,000 after acquiring an additional 238,064 shares during the last quarter. Geneva Partners LLC purchased a new position in Ryan Specialty in the 3rd quarter worth approximately $2,537,000. Finally, Bar Harbor Wealth Management lifted its position in Ryan Specialty by 5.9% in the 4th quarter. Bar Harbor Wealth Management now owns 168,871 shares of the company’s stock valued at $10,835,000 after acquiring an additional 9,482 shares in the last quarter. Institutional investors own 84.82% of the company’s stock.

Wall Street Analysts Forecast Growth

RYAN has been the topic of several recent analyst reports. Keefe, Bruyette & Woods cut their target price on Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating on the stock in a research note on Friday, January 10th. Barclays lifted their price objective on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research report on Thursday, November 21st. Morgan Stanley began coverage on Ryan Specialty in a report on Thursday, December 5th. They set an “overweight” rating and a $90.00 target price for the company. Wells Fargo & Company cut their price target on shares of Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating on the stock in a report on Tuesday, January 14th. Finally, BMO Capital Markets raised shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and boosted their price objective for the company from $65.00 to $75.00 in a research report on Tuesday, September 24th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $74.40.

View Our Latest Research Report on Ryan Specialty

About Ryan Specialty

(Get Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Stories

Insider Buying and Selling by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.